Diversity Action Plans in Clinical Trials
- PMID: 39302828
- DOI: 10.1001/jama.2024.16009
Diversity Action Plans in Clinical Trials
Plain language summary
This Viewpoint discusses the US Food and Drug Administration’s upcoming mandate on diversity actions plans for trial sponsors and the importance of developing accountability mechanisms to monitor those plans.
LinkOut - more resources
Full Text Sources
